Dr Nazila Kamaly, joined Imperial College London Department of Chemisty as faculty in 2019. She was previously an Associate Professor at the Technical University of Denmark, where she was awarded a Lundbeck Fellowship to develop targeted nanomedicines for heart disease. Before that she held Instructor and Postdoc positions at Harvard Medical School and MIT from 2011-2016. Previous to this she held a Postdoc position and also conducted her PhD in the Chemistry Department at Imperial College London, and holds an MSci degree in Medicinal Chemistry from University College London. She has been developing nanomedicines, nanodiagnostics and nanotheranostics for almost 2 decades.



